
Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.
Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.
Methotrexate is an immunosuppressive agent used to treat cancer, dermatology-, and rheumatology-related issues.
Sonidegib is a biphenyl carboxamide that blocks the signaling in the hedgehog pathway.
Sacubitril/valsartan (Entresto)reduces the risk of hospitalization and death related to cardiovascular complications in patients with heart failure.
Evusheld has been found to significantly reduce the risk of developing symptomatic COVID-19.